Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Nichol

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Thrombosis and Haemostasis|December 14, 1999
Haematological abnormalities in early abstinent alcoholics are closely associated with alterations in thrombopoietin and erythropoietin serum profilesM Schmitt, C H Gleiter, J L Nichol, et al.
British Journal of Haematology|March 21, 1998
Thrombopoietin serum levels in patients with aplastic anaemia: correlation with platelet count and persistent elevation in remissionH Schrezenmeier, M Griesshammer, A Hornkohl, et al.
Blood|November 14, 1997
Chronic thrombocytopenia is induced in dogs by development of cross-reacting antibodies to the MpL ligandD C Dale, J L Nichol, D A Rich, et al.
Stem Cells (Dayton, Ohio)|September 1, 1994
Enrichment and characterization of peripheral blood-derived megakaryocyte progenitors that mature in short-term liquid cultureJ L Nichol, A C Hornkohl, E S Choi, et al.
Lupus|June 5, 2002
Serum thrombopoietin levels and anti-thrombopoietin antibodies in systemic lupus erythematosusW Füreder, U Firbas, J L Nichol, et al.
Journal of Thrombosis and Haemostasis : JTH|March 17, 2010
Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP)T B Gernsheimer, J N George, L M Aledort, et al.
Blood|January 1, 1997
Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factorL A Harker, U M Marzec, A B Kelly, et al.
Stem Cells (Dayton, Ohio)|May 1, 1995
Recombinant human megakaryocyte growth and development factor (rHuMGDF), a ligand for c-Mpl, produces functional human platelets in vitroE S Choi, M Hokom, T Bartley, et al.
British Journal of Haematology|December 1, 1996
Serum thrombopoietin levels in patients with aplastic anaemiaJ C Marsh, F M Gibson, R L Prue, et al.
The Journal of Clinical Investigation|June 1, 1995
Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopeniaJ L Nichol, M M Hokom, A Hornkohl, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Thrombosis and Haemostasis|December 14, 1999
Haematological abnormalities in early abstinent alcoholics are closely associated with alterations in thrombopoietin and erythropoietin serum profilesM Schmitt, C H Gleiter, J L Nichol, et al.
British Journal of Haematology|March 21, 1998
Thrombopoietin serum levels in patients with aplastic anaemia: correlation with platelet count and persistent elevation in remissionH Schrezenmeier, M Griesshammer, A Hornkohl, et al.
Blood|November 14, 1997
Chronic thrombocytopenia is induced in dogs by development of cross-reacting antibodies to the MpL ligandD C Dale, J L Nichol, D A Rich, et al.
Stem Cells (Dayton, Ohio)|September 1, 1994
Enrichment and characterization of peripheral blood-derived megakaryocyte progenitors that mature in short-term liquid cultureJ L Nichol, A C Hornkohl, E S Choi, et al.
Lupus|June 5, 2002
Serum thrombopoietin levels and anti-thrombopoietin antibodies in systemic lupus erythematosusW Füreder, U Firbas, J L Nichol, et al.
Journal of Thrombosis and Haemostasis : JTH|March 17, 2010
Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP)T B Gernsheimer, J N George, L M Aledort, et al.
Blood|January 1, 1997
Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factorL A Harker, U M Marzec, A B Kelly, et al.
Stem Cells (Dayton, Ohio)|May 1, 1995
Recombinant human megakaryocyte growth and development factor (rHuMGDF), a ligand for c-Mpl, produces functional human platelets in vitroE S Choi, M Hokom, T Bartley, et al.
British Journal of Haematology|December 1, 1996
Serum thrombopoietin levels in patients with aplastic anaemiaJ C Marsh, F M Gibson, R L Prue, et al.
The Journal of Clinical Investigation|June 1, 1995
Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopeniaJ L Nichol, M M Hokom, A Hornkohl, et al.
Pageof 3